(Q39705901)

14 September 2017

Mining the malignant ascites proteome for pancreatic cancer biomarkers (English)

1 reference

14 September 2017

0 references

1 reference

Eleftherios P. Diamandis

5

1 reference

14 September 2017

Hari Kosanam

1

0 references

author name string

Shalini Makawita

2

1 reference

14 September 2017

Bramford Judd

3

1 reference

14 September 2017

Alice Newman

4

1 reference

14 September 2017

language of work or name

1 reference

28 October 2011

1 reference

14 September 2017

1 reference

14 September 2017

11

1 reference

14 September 2017

23

1 reference

14 September 2017

4551-4558

1 reference

14 September 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

The case for early detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Early diagnosis of small pancreatic cancer: role of endoscopic ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Limitations in improving detection of pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Malignant ascites: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Pathogenesis of malignant ascites: Starling's law of capillary hemodynamics revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Prognostic significance of new onset ascites in patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Nidogen-2: a new serum biomarker for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Evaluation of two different albumin depletion strategies for improved analysis of human CSF by SELDI-TOF-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Comparison of different depletion strategies for improving resolution of the human urine proteome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Standardisation of rapid in-gel digestion by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Proteomic analysis of seminal plasma from normal volunteers and post-vasectomy patients identifies over 2000 proteins and candidate biomarkers of the urogenital system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Nipple aspirate fluid proteome of healthy females and patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

A compendium of potential biomarkers of pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

CEACAM1 expression in pancreatic endocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

HIP2: an online database of human plasma proteins from healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

A Proteome Resource of Ovarian Cancer Ascites: Integrated Proteomic and Bioinformatic Analyses To Identify Putative Biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

Proteomics Analysis of Human Amniotic Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100264

21 January 2018

Identifiers

DOI

10.1002/PMIC.201100264

1 reference

14 September 2017

1 reference